Boston Scientific, Guidant Pay $30M To Settle False Claims Involving Heart Devices

Boston Scientific, Guidant Pay $30M To Settle False Claims Involving Heart Devices

WASHINGTON, D.C. - Boston Scientific Corp. and its Guidant subsidiaries have agreed to pay $30 million to settle a whistle-blower lawsuit alleging that between 2002 and 2005 the defendants caused the submission of false claims to Medicare for implantable cardioverter defibrillators (ICDs) that they knew were defective, the U.S. Justice Department said in an Oct. 17 press release (United States of America, ex rel. James Allen v. Guidant Corporation, et al., No. 22-22, D. Minn.).

Find full version on lexis Advance®
Access this news story on lexis.com®